GENERIC NAME OF THE MEDICINAL PRODUCT:

a) Molnupiravir Capsules 200mg
b) Molnupiravir Capsules 400mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

a) Molnupiravir Capsules 200mg
Each capsule contains:
Molnupiravir………….…..200mg
Excipients……………………q.s.
Colours: Approved colours used in capsule shell


b) Molnupiravir Capsules 400mg
Each capsule contains:
Molnupiravir……….……..400mg
Excipients……………………q.s.
Colours: Approved colours used in capsule shell

THERAPEUTIC INDICATIONS:

Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.

CAUTION & WARNING:

Caution:
Read the package leaflet before use.
Capsules should be swallowed whole & not to be opened, chewed or crushed.
Dispense in original container. Keep the container tightly closed.
Keep out of reach and sight of children.
To be distributed and used in licensed countries only.

Warning: To be sold by retail on the prescription of Medical Specialist only.

NOT TO EXCEED PRESCRIBED DOSAGE.

STORAGE & DOSAGE:

Storage: Store protected from moisture at a temperature not exceeding 30°C. Do not refrigerate.

Dosage: As directed by the Physician.

Molnupiravir Capsules Technical Specifications:

Product Name:Molnupiravir Capsules
Brand Name:Molnutaj
Strength:200mg, 400mg
Dosage Form:Hard-Gelatin Capsules
Packing:10s, 40s
Route of Administration:For Oral Use only.
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Antiviral, COVID-19
Indication: Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2. This medicine reduces the replication of SARS-CoV-2, and prevents infectious virus with rapid speed.
Storage:Store protected from moisture at a temperature not exceeding 30°C. Do not refrigerate.
Special Warning:*Do not skip/discontinue the dose for effective treatment*. TO BE CONSUMED AS DIRECTED BY THE PHYSICIAN. Maintain hygiene, and do not come in contact with infected persons.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  1. Molnupiravir Capsules 200mg
  2. Molnupiravir Capsules 400mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

1. Molnupiravir Capsules 200mg
Each capsule contains:
Molnupiravir………….…..200mg
Excipients……………………q.s.
Colours: Approved colours used in capsule shell

2. Molnupiravir Capsules 400mg
Each capsule contains:
Molnupiravir……….……..400mg
Excipients……………………q.s.
Colours: Approved colours used in capsule shell

THERAPEUTIC INDICATIONS:

Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2. This medicine reduces the replication of SARS-CoV-2, and prevents infectious virus with rapid speed.

CAUTION & WARNING:

Warning: To be sold by retail on the prescription of Medical Specialist only.

NOT TO EXCEED PRESCRIBED DOSAGE.

Indications, Warnings & Precautions:

Read the package leaflet before use.

Capsules should be swallowed whole & not to be opened, chewed or crushed.

Dispense in original container.

Keep the container tightly closed.

Keep out of reach and sight of children.

To be distributed and used in licensed countries only.

STORAGE & DOSAGE:

Storage: Store protected from moisture at a temperature not exceeding 30°C. Do not refrigerate.

Dosage: As directed by the Physician.

Special Warning: Do not skip/discontinue the dose for effective treatment. TO BE CONSUMED AS DIRECTED BY THE PHYSICIAN.

Maintain hygiene, and do not come in contact with infected persons.

Note: Approved for Restricted use in Emergency.

Why Taj pharmaceuticals?

Taj Pharmaceuticals is a leading provider of Molnupiravir Capsules, an antiviral breakthrough that has been instrumental in the fight against COVID-19. With our unwavering dedication to pharmaceutical excellence, quality assurance, and patient-centric care, we have become a trusted partner in the global effort to combat infectious diseases. Our commitment to public health extends to ensuring that Molnupiravir Capsules are produced in compliance with the highest global standards of quality and safety. We prioritize accessibility, making this critical medication available to healthcare providers and patients worldwide to help mitigate the impact of the pandemic. At Taj Pharmaceuticals, we believe in the power of innovation and research-driven solutions to address the world’s most pressing healthcare challenges. Molnupiravir Capsules represent a significant advancement in antiviral therapy, and our role as a reliable pharmaceutical partner underscores our dedication to improving patient outcomes. Choose Taj Pharmaceuticals for Molnupiravir Capsules and access pharmaceutical expertise that places patient well-being at the forefront. We are committed to contributing to the global fight against infectious diseases, with a focus on delivering quality medications that make a difference in the lives of individuals and communities. Trust Taj Pharmaceuticals for your antiviral needs.

What is Molnupiravir Capsules and its uses?

Molnupiravir Capsules is an antiviral medication that has gained significant attention for its potential use in the treatment of COVID19. Let’s explore its uses:

  1. Treatment of COVID19:

Molnupiravir Capsules have been developed as a potential treatment for COVID19, the disease caused by the SARSCoV2 virus.

It is intended for use in adult patients with COVID19 who have mild to moderate symptoms and are at risk of developing severe disease.

Molnupiravir is believed to work by introducing errors in the genetic material (RNA) of the virus during replication, thereby inhibiting the virus’s ability to reproduce and spread within the body.

  1. Reducing Viral Load:

The primary goal of Molnupiravir treatment is to reduce the viral load in infected individuals, which may contribute to faster recovery and a lower risk of severe illness.

  1. Potential for Early Intervention:

Molnupiravir may be particularly beneficial when administered early in the course of the illness, as it has the potential to prevent the progression of the disease to a more severe stage.

  1. Emerging Research:

It’s important to note that research on the effectiveness of Molnupiravir is ongoing, and its role in COVID19 treatment is continually being studied. As such, its availability and recommended usage may vary by region and evolve over time based on emerging data.

  1. Global Efforts Against COVID19:

Molnupiravir is one of several antiviral drugs that have been developed and tested as part of the global effort to combat the COVID19 pandemic. Its development represents a significant step in the search for effective treatments against the virus.

  1. Potential Future Uses:

Beyond COVID19, there is ongoing research into the potential use of Molnupiravir in the treatment of other viral infections, making it a subject of interest in the field of antiviral therapy.

It’s important to note that the use of Molnupiravir Capsules, its availability, and the specific guidelines for its administration may vary by country and region. Healthcare providers will determine the suitability of this medication for individual patients based on their clinical condition, risk factors, and available treatment options. Patients should follow their healthcare provider’s guidance regarding the use of Molnupiravir for COVID19 or any other condition.

How does Molnupiravir Capsules Work?

Molnupiravir Capsules work as an antiviral medication by targeting the genetic material of the SARSCoV2 virus, which causes COVID19. Here’s how Molnupiravir works:

  1. RNA Virus Inhibition: SARSCoV2 is an RNA virus, meaning its genetic material is composed of ribonucleic acid (RNA). To replicate and produce new viral particles, the virus relies on a key enzyme called RNA-dependent RNA polymerase (RdRp). Molnupiravir is designed to interfere with the activity of RdRp, which is essential for viral replication.
  1. Incorporation into Viral RNA: When a person takes Molnupiravir Capsules, the medication is absorbed into the bloodstream and eventually enters infected cells where the virus is actively replicating. Molnupiravir is converted into its active form within these infected cells.
  1. Mimicking Nucleotides: In its active form, Molnupiravir resembles one of the building blocks of RNA, specifically cytidine (a nucleoside analog). During the viral RNA replication process, when the virus attempts to build a new RNA strand, it may mistakenly incorporate Molnupiravir into the growing RNA chain.
  1. Introduction of Errors: Molnupiravir’s incorporation into the viral RNA disrupts the normal RNA synthesis process. This can lead to the introduction of errors or mutations in the viral genetic code.
  1. Faulty Viral Replication: The presence of errors in the viral RNA makes it difficult for the virus to replicate accurately. As a result, the newly formed viral particles may contain defective genetic material.
  1. Reduced Infectivity: Viral particles with faulty genetic material are often less capable of infecting new cells and may be non-functional.
  1. Lower Viral Load: Molnupiravir’s interference with viral replication leads to a reduced viral load in the patient’s body. Lower viral loads are associated with milder symptoms and a decreased risk of severe illness.
  1. Faster Recovery: By limiting the virus’s ability to replicate effectively, Molnupiravir may contribute to a faster recovery from COVID19, particularly in patients with mild to moderate symptoms.

It’s important to note that Molnupiravir’s mechanism of action is specific to the SARSCoV2 virus and does not affect the genetic material of human cells. This targeted approach aims to disrupt the virus’s ability to reproduce while minimizing the impact on the patient’s own cells. Research on Molnupiravir’s efficacy and safety in treating COVID19 is ongoing, and its use is subject to regulatory approvals and specific clinical guidelines. Patients should use this medication under the supervision and guidance of healthcare professionals.

Benefits of Molnupiravir Capsules:

  • Antiviral Action: Molnupiravir has demonstrated antiviral activity against the SARS-CoV-2 virus, which causes COVID-19. It inhibits viral replication, potentially reducing the viral load in infected individuals.
  • Treatment for COVID-19: Molnupiravir is used as a treatment for COVID-19, particularly in adults with mild to moderate symptoms. It may help prevent the progression of the disease to a severe stage.
  • Reduced Risk of Severe Illness: By limiting viral replication, Molnupiravir may reduce the risk of severe illness, hospitalization, and complications associated with COVID-19.
  • Faster Recovery: Patients with COVID-19 who receive Molnupiravir may experience faster recovery times, allowing them to return to their normal activities sooner.
  • Potential for Early Intervention: The medication is most effective when administered early in the course of the illness, which can be crucial in preventing the virus from spreading within the body.

Side Effects of Molnupiravir Capsules:

  • Gastrointestinal Disturbances: Common side effects may include nausea, diarrhea, and abdominal discomfort. These symptoms are generally mild and temporary.
  • Headache: Some individuals may experience headaches while taking Molnupiravir.
  • Allergic Reactions: Allergic reactions, though rare, can occur. Symptoms may include rash, itching, swelling, and difficulty breathing. Allergic reactions should be reported promptly to a healthcare provider.
  • Interaction with Other Medications: Molnupiravir may interact with certain medications. Patients should inform their healthcare provider of all medications they are taking to check for potential drug interactions.
  • Safety in Pregnancy and Breastfeeding: The safety of Molnupiravir during pregnancy and breastfeeding is not well-established, and its use in these situations should be carefully considered in consultation with healthcare providers.
  • Emerging Data: As with any newly developed medication, ongoing research is needed to fully understand its safety profile. Additional side effects may become apparent as more data is collected during real-world use.

It’s important for patients to discuss any side effects or concerns with their healthcare provider. The decision to use Molnupiravir should be based on a careful assessment of the patient’s condition, potential benefits, and risks. Patients should also follow their healthcare provider’s instructions regarding the dosage and duration of treatment. Molnupiravir is typically used under emergency use authorization or specific regulatory approvals in various regions, and its availability and recommended use may vary.

Frequently Asked Questions About Molnupiravir Capsules:

Certainly, here are some frequently asked questions (FAQs) about Molnupiravir Capsules:

  1. What is Molnupiravir, and how does it work?

Molnupiravir is an antiviral medication used to treat COVID19. It works by interfering with the replication of the SARSCoV2 virus, potentially reducing the viral load and severity of the disease.

  1. Who can take Molnupiravir Capsules?

Molnupiravir is typically prescribed for adults with mild to moderate COVID19 symptoms who are at risk of developing severe illness.

  1. Is Molnupiravir a substitute for COVID19 vaccines?

No, Molnupiravir is not a vaccine and does not prevent COVID19. It is used as a treatment for individuals who have already contracted the virus.

  1. When should I take Molnupiravir?

The medication is most effective when administered early in the course of COVID19, preferably within the first few days of symptom onset.

  1. What are the potential side effects of Molnupiravir?

Common side effects may include nausea, diarrhea, headache, and gastrointestinal discomfort. Allergic reactions are rare but possible.

  1. Can Molnupiravir be used during pregnancy or while breastfeeding?

The safety of Molnupiravir in pregnancy and breastfeeding is not wellestablished, and its use in these situations should be discussed with a healthcare provider.

  1. Is Molnupiravir effective against new variants of the virus?

Research on Molnupiravir’s effectiveness against different variants of the virus is ongoing. It may have varying efficacy against different strains.

  1. Does Molnupiravir require a prescription?

Yes, Molnupiravir is a prescription medication. It should only be used under the guidance and supervision of a healthcare provider.

  1. Is there a specific dosage for Molnupiravir?

The dosage and treatment duration may vary based on healthcare provider recommendations and regional guidelines. Follow your healthcare provider’s instructions.

  1. Can Molnupiravir be used as a preventive measure against COVID19?

Molnupiravir is intended for the treatment of COVID19, not as a preventive measure. Vaccination remains the primary preventive strategy.

  1. Where can I obtain Molnupiravir Capsules?

Molnupiravir may be available in some regions under emergency use authorization or specific regulatory approvals. Check with local healthcare authorities for availability and guidelines.

  1. Are there any known drug interactions with Molnupiravir?

Molnupiravir may interact with certain medications. Inform your healthcare provider of all medications you are taking to check for potential interactions.

Patients should consult their healthcare provider for personalized information and guidance regarding the use of Molnupiravir, including dosage, potential side effects, and any specific questions or concerns they may have.

As Molnupiravir Capsules Exporters; We can cater to export business queries from the following geographies. We are exporting our Molnupiravir Capsules product in the Following Countries-

Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine

GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, and Iraq.

African Countries: Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia

Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam

Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius

Molnupiravir Capsules Injection Regulatory Documents:

  • Certificate of Analysis (COA)
  • Method of Analysis (MOA)
  • Stability Data (Accelerated stability / Long-term stability / Zone 4b)
  • CTD Dossier / ACTD Dossiers / eCTD Dossiers
  • Certificate of Pharmaceuticals Product (COPP)
  • Free Sale Certificate (FSC)
Contact the most reliable manufacturer of Molnupiravir Capsules, Taj Pharmaceuticals Limited, to get bulk quantities at a reasonable price.

To Place Orders:

Direct line: +91 8448 444 095 / WhatsApp +91 74 0000 9975 / 74 0000 9976
E-Mail: info@tajpharma.com 
Toll free: 1-800-222-434 / Toll free: 1-800-222-825
General EPA BX: +91 22 2637 4592 / +91 22 2637 4593